Back

Omega-3 Fatty Acids

modulating inflammatory responses

Evidence · Grade D
Meta-analysis availableSystematic review availableHuman trial evidenceInteraction riskNeeds more research

Omega-3 fatty acids are essential polyunsaturated fats, primarily EPA and DHA, that may influence inflammatory and immune pathways, with ongoing research into their potential health applications.

Omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are polyunsaturated fatty acids found in fish oil and some plant sources. They are recognized for their beneficial effects on cardiovascular health, including their potential role in mitigating atherosclerosis.

Quick answer

Evidence Summary

Evidence · Grade D

The current evidence for omega-3 fatty acids in specific conditions is limited. For Multiple Sclerosis (MS), one human clinical trial suggests that fish oil may impact inflammatory markers like TNFα, IL-1β, and IL-6. However, this single study is insufficient to draw broad conclusions about clinical efficacy.

Last reviewed · Jun 2026

Have you tried Omega-3 Fatty Acids?

Vote in 5 seconds. Add details if you want.

Your experience for Multiple Sclerosis (MS):

Commonly Combined With

Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.

Community signal breakdown

Where this remedy is being discussed across the web and community.

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community Discussions

What people say about Omega-3 Fatty Acids

Search on Reddit →

Latest News

Latest news on Omega-3 Fatty Acids

More on Google News →

Health Videos

Health videos on Omega-3 Fatty Acids

More on YouTube

Why It Works

Omega-3 fatty acids exert their atheroprotective effects through several mechanisms, including reducing triglyceride levels, lowering blood pressure, improving endothelial function, and exhibiting anti-inflammatory and anti-thrombotic properties. They can also inhibit the proliferation of smooth muscle cells and reduce the oxidation of low-density lipoprotein (LDL).

How it works in more detail

Omega-3 fatty acids, specifically EPA and DHA, are incorporated into cell membranes, where they can alter membrane fluidity and receptor function. They serve as precursors for the synthesis of specialized pro-resolving mediators (SPMs) such as resolvins, protectins, and maresins, which actively resolve inflammation. EPA can also compete with arachidonic acid (an omega-6 fatty acid) for enzymes like cyclooxygenase (COX) and lipoxygenase (LOX), leading to the production of less inflammatory eicosanoids (e.g., prostaglandin E3, leukotriene B5) compared to those derived from arachidonic acid (e.g., prostaglandin E2, leukotriene B4). This shift in eicosanoid production contributes to their anti-inflammatory effects. Additionally, omega-3s may influence gene expression related to inflammation and immune function.

How to use

Always consult a qualified clinician.

Editorial guidance

Suggested dosage
Typically 1-4 grams per day of combined EPA and DHA, often requiring a doctor's recommendation for higher doses.
Research dosage range
In one study for Multiple Sclerosis, fish oil was used.
Typical forms
capsule, softgel, liquid oil
Quality markers
Look for products that specify the amounts of EPA and DHA. Third-party testing for purity, potency, and absence of contaminants like heavy metals (e.g., mercury) and PCBs is also important. Enteric-coated capsules may help reduce 'fish burps'.
Medication interactions
  • Anticoagulants (blood thinners)
  • Antiplatelet drugs
  • Blood pressure medications

Community tips

No community tips yet — be the first to share what worked for you.

Suggested dosage

Typically 1-4 grams per day of combined EPA and DHA, often requiring a doctor's recommendation for higher doses.

General guidance — discuss specifics with a clinician.

Active medicinal compounds

Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA), Alpha-linolenic acid (ALA)

Safety

Safety warnings

Generally safe for most adults. Possible side effects include a fishy aftertaste, gastrointestinal upset, and increased risk of bleeding at very high doses.

Medication interactions

  • Anticoagulants (blood thinners)
  • Antiplatelet drugs
  • Blood pressure medications

Reported side effects

  • Fishy aftertaste
  • Bad breath
  • Heartburn
  • Nausea
  • Diarrhea
  • Headache

General guidance — discuss specifics with a clinician.

Evidence ecosystem

Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.

Overall grade (D)

The current evidence for omega-3 fatty acids in specific conditions is limited. For Multiple Sclerosis (MS), one human clinical trial suggests that fish oil may impact inflammatory markers like TNFα, IL-1β, and IL-6. However, this single study is insufficient to draw broad conclusions about clinical efficacy.

Filter by source type

Meta-Analyses(9)

Pooled analyses across multiple human trials.

Very High Quality
  • Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword.

    O'Keefe EL, O'Keefe JH, Abuissa H, Metzinger M, Murray E, Franco G · Progress in cardiovascular diseases · 2025

    Studies regarding effects of omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on risk of atrial fibrillation (AF) have reported discordant results. The aim of this review is to clarify effects of marine omega-3 intake on risk of AF. A PubMed search was performed using terms: atrial fibrillation, omega-3, EPA, DHA, vagal tone. We summarized findings from randomized clinical trials (RCTs), epidemiology studies, and meta-analyses evaluating effects/associations of DHA + EPA on risk of AF. Also, vagal tone was explored as a mediator between omega-3 and risk of AF. Meta-analyses of 8 RCTs and 17 prospective cohort studies comprised of 83,112 and 54,799 individuals, respectively, investigated the link between omega-3 intake and incident AF. The RCTs reported that treatment with DHA and/or EPA was associated with a 24 % increased relative risk of AF (absolute risk 4.0 % vs 3.3 %; relative risk [RR] 1.24, 95 % confide

    Meta-AnalysisPubMedVery High Quality
  • Vitamin D supplementation vs. placebo and incident type 2 diabetes in an ancillary study of the randomized Vitamin D and Omega-3 Trial.

    Tobias DK, Pradhan AD, Duran EK, Li C, Song Y, Buring JE · Nature communications · 2025 · n=220

    Observational and experimental evidence suggests that vitamin D plays a role in type 2 diabetes (T2D). However, prior randomized supplementation trials are limited to high-risk patients with prediabetes. Here we aim to evaluate whether vitamin D supplementation reduces risk of T2D in a general population of older US adults. The study design is an ancillary analysis (VITAL-T2D) of The Vitamin D and Omega-3 Trial (VITAL), a completed randomized, double-blind, placebo-controlled 2 × 2 trial of daily vitamin D3 (cholecalciferol; 2000 IU/day) and omega-3 fatty acids (1 g/day) for the primary prevention of cancer and cardiovascular disease. We also conducted a systematic review and meta-analysis of vitamin D trial (≥1000 IU/d cholecalciferol) vs. placebo and T2D risk. We analyzed 22,220 adults with mean age 67.2 years (SD = 7.1) without T2D at enrollment (2011 to 2014), randomized to vitamin D3 or placebo. Mean body mass index (BMI) was 27.5&#x2

    Meta-AnalysisPubMedVery High Quality
  • Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis.

    Yan J, Liu M, Yang D, Zhang Y, An F · Cardiovascular drugs and therapy · 2024

    It is widely accepted that omega-3 fatty acids are beneficial in the prevention of cardiovascular disease, but many large randomized controlled trial studies and meta-analyses have come to different conclusions. The evidence for omega-3 fatty acids supplementation to prevent cardiovascular disease remains insufficient. We conducted a systematic review and meta-analysis to evaluate the efficacy and safety of several types of omega-3 fatty acids supplements. We comprehensively searched the online database and found 15 RCTs. The primary efficacy outcomes included major cardiovascular events, myocardial infarction, heart failure, atrial fibrillation, stroke, cardiovascular death, and all-cause death. The safety endpoints included gastrointestinal problems, bleeding-related disorders, and cancer. Subgroup analysis was conducted according to the main characteristics of the population, and the dose-response relationship of omega-3 fatty acids was evaluated by meta-regression. All results wer

    Meta-AnalysisPubMedVery High Quality

Systematic Reviews(4)

Structured reviews of the full body of evidence (incl. Cochrane).

Very High Quality
  • Nutraceuticals in Psychiatric Disorders: A Systematic Review.

    Bozzatello P, Novelli R, Montemagni C, Rocca P, Bellino S · International journal of molecular sciences · 2024

    Correct nutrition and diet are directly correlated with mental health, functions of the immune system, and gut microbiota composition. Diets with a high content of some nutrients, such as fibers, phytochemicals, and short-chain fatty acids (omega-3 fatty acids), seem to have an anti-inflammatory and protective action on the nervous system. Among nutraceuticals, supplementation of probiotics and omega-3 fatty acids plays a role in improving symptoms of several mental disorders. In this review, we collect data on the efficacy of nutraceuticals in patients with schizophrenia, autism spectrum disorders, major depression, bipolar disorder, and personality disorders. This narrative review aims to provide an overview of recent evidence obtained on this topic, pointing out the direction for future research.

    Systematic ReviewPubMedVery High Quality
  • Fish and human health: an umbrella review of observational studies.

    Jurek J, Owczarek M, Godos J, La Vignera S, Condorelli RA, Marventano S · International journal of food sciences and nutrition · 2022

    Fish represents one of the most important dietary sources of omega-3 polyunsaturated fatty acids, which are known to be associated with various health benefits. This study aimed to systematically review existing meta-analyses of observational studies exploring the association between fish intake and various health outcomes. A systematic search of electronic databases was conducted to retrieve a total of 63 studies. Evidence was deemed as possible for the association between higher fish intake and decreased risk of the acute coronary syndrome, liver cancer, and depression, and limited for other outcomes (including age-related macular degeneration, Alzheimer's disease, heart failure, all-cause and coronary heart disease mortality, total and ischaemic stroke) due to heterogeneity between results and potential otherwise inexplicable confounding factors. In conclusion, results from epidemiological studies support the mechanistic effects associated with omega-3 fatty acids from high fish con

    Systematic ReviewPubMedVery High Quality
  • Prevention and Treatment of Atrial Fibrillation via Risk Factor Modification.

    O'Keefe EL, Sturgess JE, O'Keefe JH, Gupta S, Lavie CJ · The American journal of cardiology · 2021

    Atrial fibrillation (AF) is the most common clinically significant arrhythmia, and it increases stroke risk. A preventive approach to AF is needed because virtually all treatments such as cardioversion, antiarrhythmic drugs, ablation, and anticoagulation are associated with high cost and carry significant risk. A systematic review was performed to identify effective lifestyle-based strategies for reducing primary and secondary AF. A PubMed search was performed using articles up to March 1, 2021. Search terms included atrial fibrillation, atrial flutter, exercise, diet, metabolic syndrome, type 2 diabetes mellitus, obesity, hypertension, stress, tobacco smoking, alcohol, Mediterranean diet, sodium, and omega-3 fatty acids. Additional articles were identified from the bibliographies of retrieved articles. The control of hypertension, ideally with a renin-angiotensin-aldosterone system inhibitor, is effective for preventing primary AF and recurrence. Obstructive sleep apnea is a common ca

    Systematic ReviewPubMedVery High Quality

Clinical Guidelines(3)

Recommendations from medical societies (NICE, AHA, ADA, ACG, Endocrine Society…).

High Quality
  • ESPEN guideline on clinical nutrition in the intensive care unit.

    Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP · Clinical nutrition (Edinburgh, Scotland) · 2019

    Following the new ESPEN Standard Operating Procedures, the previous guidelines to provide best medical nutritional therapy to critically ill patients have been updated. These guidelines define who are the patients at risk, how to assess nutritional status of an ICU patient, how to define the amount of energy to provide, the route to choose and how to adapt according to various clinical conditions. When to start and how to progress in the administration of adequate provision of nutrients is also described. The best determination of amount and nature of carbohydrates, fat and protein are suggested. Special attention is given to glutamine and omega-3 fatty acids. Particular conditions frequently observed in intensive care such as patients with dysphagia, frail patients, multiple trauma patients, abdominal surgery, sepsis, and obesity are discussed to guide the practitioner toward the best evidence based therapy. Monitoring of this nutritional therapy is discussed in a separate document.

    Clinical GuidelinePubMed (Practice Guideline)Very High Quality
  • Fish and Omega-3 Fatty Acids

    AHA

    The American Heart Association provides recommendations on the consumption of fish and omega-3 fatty acids for cardiovascular health. This guidance helps individuals understand the benefits and appropriate intake of these nutrients.

    Clinical GuidelineAHAHigh Quality
  • Omega-3 Fatty Acids

    AHA

    The American Heart Association provides information on omega-3 fatty acids focusing on their role in cardiovascular health. It offers dietary recommendations and discusses supplements in the context of heart disease prevention.

    Clinical GuidelineAHAHigh Quality

Randomized Human Trials(8)

Controlled human studies with random assignment.

High Quality
  • Effects of Omega-3 Fatty Acids on Tobacco Craving in Tobacco Users: A Single-blind, Randomized, Placebo-controlled Study.

    Singh A, Verma N, Kant S, Verma AK, Tripathi A, Bhardwaj K · The Journal of the Association of Physicians of India · 2026 · n=83

    Tobacco use and its smoke produces oxidative stress in the body, which eventually triggers cell damage by lipid peroxidation. Smokers report lower levels of omega-3 fatty acids (FAs) in their serum as compared to nonsmokers. Omega-3 deficiency impairs neurotransmission, resulting in hypofunctioning of the mesocortical system, which is a reward and dependency system that can raise tobacco cravings, disrupting tobacco quitting efforts. Omega-3 polyunsaturated fatty acid (PUFA) regulates stress, anxiety, and negative emotions that are associated with tobacco urges. Limited research has assessed the supplementation effect of omega-3 PUFA [in the form of alpha-linolenic acid (ALA)] on tobacco craving. We aimed to explore the effects of omega-3 PUFA (ALA) on the frequency of tobacco use per day, tobacco dependence, and tobacco craving when compared to placebo in regular tobacco users. Regular tobacco users (n = 83) recruited from the Tobacco Cessation Clinic were randomly allocated to two

    Randomized TrialPubMedHigh Quality
  • Environmental Factors in Type 1 Diabetes.

    Hyöty H, Laiho JE, Virtanen SM · Cold Spring Harbor perspectives in medicine · 2026

    The contribution of environmental factors to the pathogenesis of type 1 diabetes is considered substantial, but their identification has turned out to be challenging. Large prospective studies are crucial for reliable identification of environmental risk and protective factors. However, only few large prospective birth cohort studies have been carried out. Enterovirus infections have shown quite consistent risk association with the initiation of islet autoimmunity (IA) across these studies. Also, certain dietary factors have been consistently associated with IA risk, omega-3 fatty acids inversely, and childhood cow's milk intake directly. However, the mechanisms of these associations are not fully understood, and possible causality has not been confirmed. Clinical trial programs with enterovirus vaccines and antiviral drugs are in progress to evaluate the causality of enterovirus association. The only nutritional primary prevention randomized trial, TRIGR, did not find a difference bet

    Randomized TrialPubMedHigh Quality
  • Omega-3 fatty acids, brain health and the menopause.

    Minihane AM · Post reproductive health · 2025

    The menopausal transition is associated with vasomotor symptoms, disrupted sleep, transient cognitive deficits and changes in mood and anxiety levels, underpinned by declining and erratic estrogen availability in the brain. Relative to other tissues the brain is enriched in the omega-3 fatty acid, docosahexaenoic (DHA), with well-defined neurophysiological roles for both eicosapentaenoic acid (EPA) and DHA. Substantial preclinical and epidemiological evidence along with accumulating randomised controlled trial (RCT) data indicates that an increase in EPA and DHA intake and status is associated with improved brain function. In this narrative review, the role of EPA and DHA in the menopausal transition (MT) is considered. The evidence, although relatively sparse, is indicative of benefit, with future RCTs needed to establish dose-response relationships and when it is most beneficial to intervene. Although research is at a relatively early stage, the MT is emerging as a critical window of

    Randomized TrialPubMedHigh Quality

Observational Studies(27)

Cohort, case-control, and cross-sectional human studies.

Moderate Quality
  • Omega-3 fatty acids in mental disorders: from neurobiological and metabolic mechanisms to therapeutic potential.

    Fleig K, Haslinger L, Dawczynski C, Kolassa IT · Frontiers in nutrition · 2026

    Nutritional psychiatry is an emerging field. Micro- and macro-nutrients play a role in energy metabolism and the regulation of inflammation; particularly, an insufficient dietary intake of omega-3 fatty acids and an imbalanced intake of omega-6/omega-3 fatty acids, with a shift toward increased inflammation, are of relevance for the pathophysiology of mental disorders. This review summarizes evidence on the role of omega-3 fatty acids in the pathophysiology of mental disorders (schizophrenia, affective and anxiety disorders, post-traumatic stress disorder, and eating disorders), neurodevelopmental disorders (attention-deficit/hyperactivity disorder and autism spectrum disorder) and neurodegenerative disorders (Alzheimer's disease) and explores potential treatment implications. In addition, the underlying neurobiological mechanisms through which omega-3 fatty acids might exert a protective effect are also discussed. Despite methodological variability and heterogeneous results, an increa

    Observational StudyPubMedLow Quality
  • The omega effect: Harnessing fish oil for health.

    Barth JD · Atherosclerosis · 2025

    Recent findings from a sub-analysis of the STRENGTH randomized clinical trial reveal that omega-3 carboxylic acids yielded significant cardiovascular risk reduction among Asian participants, despite showing neutral results in the broader high-risk cohort. These observations underscore the potential influence of genetic, metabolic, and lifestyle factors in modulating therapeutic efficacy across ethnic groups. This editorial advocates for a paradigm shift from isolated supplementation to the dietary integration of omega-3-rich foods. Nutrients derived from whole food matrices-such as fatty fish (e.g., salmon, mackerel) and plant sources (e.g., flaxseeds, walnuts)-may confer enhanced bioavailability and synergistic interactions absent in concentrated fish oil capsules. The heterogeneity of the Asian subgroup, characterized by younger age, lower adiposity, and favorable lipid profiles, complicates generalizability. Moreover, unmeasured confounders (e.g., dietary patterns, socioeconomic var

    Observational StudyPubMedLow Quality
  • Selected Lipidome Components and Their Association with Perinatal Depression.

    Ładno D, Nowak B, Palka A, Strzelecki D, Gawlik-Kotelnicka O · Nutrients · 2025

    Background/Objectives: Perinatal depression affects approximately 21% of pregnant women and 15% postpartum, significantly impacting both maternal and child health. Lipid metabolism alterations, particularly involving fatty acids and lecithin, have been associated with mood disorders during the perinatal period. Omega-3 PUFAs (polyunsaturated fatty acids) play a key role in mood regulation and neuroinflammatory processes, while lecithin significantly influences neurotransmitter synthesis. Methods: A narrative review was conducted using PubMed, Scopus and Google Scholar for relevant articles which were qualitatively analyzed. Most of the literature included was published between 2020 and 2025 with selected earlier studies used, primarily, to outline the theoretical background. Results: This narrative review highlights substantial evidence linking components of lipidome, particularly omega-3 fatty acids and lecithin, and the occurrence of perinatal depression. Omega-3 deficiency increases

    Observational StudyPubMedLow Quality

Clinical Trial Registries(24)

Registered ongoing or completed trials (ClinicalTrials.gov).

Moderate Quality
  • Intervention Study of the Ergogenic, Anti-inflammatory and Obesity Inhibitory Effects of Omega-3 Fatty Acids in 8 Year Old Children

    n=423 · NCT01323283 · COMPLETED · COMPLETED

    This study hypothesizes that supplementation of omega-3 fatty acids (OM3) can increase physical activity, inhibit rapid gain in body weight and BMI in both sedentary and normally active 8 year old children. The purpose is secondarily to explore patterns of associations between OM3 supplementation, baseline and follow-up levels in all studied parameters. The study also aims to study if basal levels of OM3 are correlated with physical activity and to study if there is an association between basal levels of OM3 and the effect of OM3 supplementation on physical activity. To study if there is an effect of OM3 supplementation on triglyceride and LDL cholesterol levels and to study if there are more pronounced effects on children with higher levels. To study if OM3 supplementation, compared with placebo reduce weight increase among children at risk to become overweight. To study if there is an association between effects of OM3 on physical activity, weight and risk markers in blood. To study if there are any gender differences.

    Clinical TrialClinicalTrials.govModerate Quality
  • Prospective Randomized Placebo Controlled Trial of Omega-3 Fatty Acids in HIV Infected Subjects to Modulate Cardiovascular Risk

    n=35 · NCT01001767 · COMPLETED · COMPLETED

    Several studies have shown that there is an increased risk of heart disease in people with HIV. In this study the investigators are looking at the effect of Lovaza (Omega-3 fatty acid) on improving endothelial function and decreasing inflammation which may contribute to this increased risk. The investigators will also be doing studies to analyze coagulation and inflammation markers.

    Clinical TrialClinicalTrials.govModerate Quality
  • Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Essential Fatty Acid Deficiency Replacement in Early Schizophrenia

    NCT00585390 · COMPLETED · COMPLETED

    The purpose of this research study is to find out what effects (good and bad) that omega-3 fatty acids has on schizophrenia.

    Clinical TrialClinicalTrials.govModerate Quality

Evidence Summaries(2)

Curated cross-source summaries (TRIP Database and similar).

High Quality
  • Cochrane Library- Omega-3 fatty acids

    Cochrane

    The Cochrane Library provides a collection of systematic reviews and meta-analyses related to omega-3 fatty acids. It synthesizes evidence to inform healthcare decisions and is considered a leading source for evidence-based medicine.

    Evidence SummaryCochraneHigh Quality
  • TRIP Database - Omega-3 Fatty Acids

    TRIP Database

    TRIP is a clinical search engine designed to allow users to quickly and easily find high-quality research evidence to support their practice. Searching for 'Omega-3 Fatty Acids' provides access to a wide range of evidence-based resources.

    Evidence SummaryTRIP DatabaseHigh Quality

Limitations: The primary limitation is the scarcity of robust clinical trials for many of the listed conditions. For MS, only one clinical trial was provided, which, while human, has a relatively small sample size (n=50). This limits the generalizability and strength of any conclusions regarding clinical outcomes or broader applicability.

This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.

Tried Omega-3 Fatty Acids?

Help others see what actually works.